Dimethyl fumarate abrogates hepatocellular carcinoma growth by inhibiting Nrf2/Bcl-xL axis and enhances sorafenib’s efficacy.
Saved in:
| Title: | Dimethyl fumarate abrogates hepatocellular carcinoma growth by inhibiting Nrf2/Bcl-xL axis and enhances sorafenib’s efficacy. |
|---|---|
| Authors: | Faleti, Oluwasijibomi Damola, Alsaadawe, Moyed, Long, Jingyi, Luo, Qingshuang, Hu, Longtai, Zhang, Yuanbin, Deng, Simin, Wu, Gongfa, Fang, Weiyi, He, Mingliang, Lyu, Xiaoming |
| Source: | Nature communications 5/14/2025; Vol. 16 (1). |
| Journal Info: | Publisher: Springer Nature ISSN: 2041-1723 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
